Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells

Journal of the National Cancer Institute

Volumn 89, Issue 1, 1997, Pages 40-48

  Ripple, Maureen O ^a   Henry, William F ^a   Rago, Randall P ^a,c   Wilding, George ^a,b  

^a UNIVERSITY OF WISCONSIN   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANTIOXIDANT; CATALASE; GAMMA GLUTAMYLTRANSFERASE;

AGING; ANDROGEN BLOOD LEVEL; ARTICLE; CARCINOMA CELL; CELL PROLIFERATION; DETOXIFICATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIPID PEROXIDATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PROSTATE CARCINOMA;

EID: 0031020769     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.1.40     Document Type: Article

References (53)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996 [see comment citation in Medline]. CA Cancer J Clin 1996;46:5-27.
2. Tanagho EA, McAninch JW, editors. Smith's general urology. Norwalk (CT): Appleton and Lange, 1995.
3. Thompson IM, Coltman CA, Brawley OW, Ryan A. Chemoprevention of prostate cancer. Semin Urol 1995;13:122-9.
4. Wilding G. Endocrine control of prostate cancer. Cancer Surv 1995;23:43-62.
5. Kaiser FE, Morley JE. Reproductive hormonal changes in the aging male. In: Timiras PS, Quay WD, Vernadakis A, editors. Hormones and aging. Boca Raton (FL): CRC Press, 1995:153-66.
6. Benzi G, Moretti A. Age-and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system. Free Radic Biol Med 1995;19:77-101.
7. Cerutti PA. Prooxidant states and tumor promotion. Science 1985;227:375-81.
8. Oberley TD, Oberley LW. Oxygen radicals and cancer. In: Yu BP, editor. Free radicals in aging. Boca Raton (FL): CRC Press, 1993:247-67.
9. Dargel R. Lipid peroxidation - a common pathogenetic mechanism? Exp Toxic Pathol 1992;44:169-81.
10. Staal FJ, Roederer M, Herzenberg LA, Herzenberg LA. Intracellular thiols regulate activation of nuclear factor κB and transcription of human immunodeficiency virus. Proc Natl Acad Sci U S A 1990;87:9943-7.
11. Abate C, Patel L, Rauscher FJ 3d, Curran T. Redox regulation of fos and jun DNA-binding activity in vitro. Science 1990;249:1157-61.
12. Toledano MB, Leonard WJ. Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci U S A 1991;88:4328-32.
13. Bergelson S, Pinkus R, Daniel V. Intracellular glutathione levels regulate Fos/Jun induction and activation of glutathione S-transferase gene expression. Cancer Res 1994;54:36-40.
14. Pinkus R, Weiner LM, Daniel V. Role of quinone-mediated generation of hydroxyl radicals in the induction of glutathione S-transferase gene expression. Biochemistry 1995;34:81-8.
15. Burdon RH, Gill V. Cellularly generated active oxygen species and HeLa cell proliferation. Free Radic Res Commun 1993;19:203-13.
16. Liehr JG, DaGue BB, Ballatore AM, Henkin J. Diethylstilbestrol (DES) quinone: a reactive intermediate in DES metabolism. Biochem Pharmacol 1983;32:3711-8.
17. Liehr JG, Roy D. Free radical generation by redox cycling of estrogens. Free Radic Biol Med 1990;8:415-23.
18. Wang MY, Liehr JG. Induction by estrogens of lipid peroxidation and lipid peroxide-derived malonaldehyde-DNA adducts in male Syrian hamsters: role of lipid peroxidation in estrogen-induced kidney carcinogenesis. Carcinogenesis 1995;16:1941-5.
19. Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 1995;87:1767-76.
20. Rousseau EJ, Davison AJ, Dunn B. Protection by beta-carotene and related compounds against oxygen-mediated cytotoxicity and genotoxicity: implications for carcinogenesis and anticarcinogenesis. Free Radic Biol Med 1992;13:407-33.
21. Bonne C, Raynaud JP. Methyltrienolone, a specific ligand for cellular androgen receptors. Steroids 1975;26:227-32.
22. Bonne C, Raynaud JP. Assay of androgen binding sites by exchange with methyltrienolone (R 1881). Steroids 1976;27:497-507.
23. 3H] methyltrienolone (R 1881) in rat prostate and human benign prostatic hypertrophy (BPH). Steroids 1976;28:449-59.
24. Tremblay RR, Dube JY, Ho-Kim MA, Lesage R. Determination of rat muscles androgen-receptor complexes with methyltrienolone. Steroids 1977;29:185-95.
25. 3H]methyltrienolone binding in rat prostate cytosol. Biochim Biophys Acta 1979;582:358-67.
26. Asselin J, Melancon R, Gourdeau Y, Labrie F, Bonne C, Raynaud JP. Specific binding of [3H]-methyltrienolone to both progestin and androgen binding components in human benign prostatic hypertrophy (BPH). J Steroid Biochem 1979;10:483-6.
27. Rago R, Mitchen J, Wilding G. DNA fluorometric assay in 96-well tissue culture plates using Hoechst 33258 after cell lysis by freezing in distilled water. Anal Biochem 1990;191:31-4.
28. Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine JS, et al. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 1993;262:1274-7.
29. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
30. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 1967;27:502-22.
31. Bump EA, Taylor YC, Brown JM. Role of glutathione in the hypoxic cell cytotoxicity of misonidazole. Cancer Res 1983;43:997-1002.
32. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
33. Luck H. Catalase. In: Bergmeyer HU, editor. Methods of enzymatic analysis. New York: Academic Press, 1965:885-8.
34. Meister A, Tate SS, Griffith OW. γ-Glutamyl transpeptidase. Methods Enzymol 1981;77:237-53.
35. Rosenkranz AR, Schmaldienst S, Stuhlmeier KM, Chen W, Knapp W, Zlabinger GJ. A microplate assay for the detection of oxidative products using 2′,7′-dichlorofluorescin-diacetate. J Immunol Methods 1992;156:39-45.
36. Tilley WD, Wilson CM, Marcelli M, McPhaul MJ. Androgen receptor gene expression in human prostate carcinoma cell lines. Cancer Res 1990;50: 5382-6.
37. Zhou ZX, Wong CI, Star M, Wilson EM. The androgen receptor: an overview. Recent Prog Horm Res 1994;49:249-74.
38. Chang C, Saltzman A, Yeh S, Young W, Keller E, Lee H-J, et al. Androgen receptor: an overview. Crit Rev Eukaryot Gene Expr 1995;5:97-125.
39. Kokontis J, Takakura K, Hay N, Liao S. Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation. Cancer Res 1994;54:1566-73.
40. Burdon RH, Allaiangana D, Gill V. Endogenously generated active oxygen species and cellular glutathione levels in relation to BHK-21 cell proliferation. Free Radic Res 1994;21:121-33.
41. Nohl H, Hegner D. Do mitochondria produce oxygen radicals in vivo? Eur J Biochem 1978;82:563-7.
42. Felton GW. Oxidative stress of vertebrates and invertebrates. In: Ahmad S, editor. Oxidative stress and antioxidant defenses in biology. New York: Chapman and Hall, 1995:356-434.
43. 2 induce catalase and metallothionein gene expression in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1995;36:1271-9.
44. Deneke SM, Fanburg BL. Regulation of cellular glutathione. Am J Physiol 1989;257(4 Pt 1):L163-73.
45. Akerboom T, Sies H. Glutathione transport and its significance in oxidative stress. In: Vina J, editor. Glutathione: metabolism and physiological functions. Boca Raton (FL): CRC Press, 1990:45-55.
46. Hanigan MH, Pitot HC. Gamma-glutamyl transpeptidase - its role in hepatocarcinogenesis. Carcinogenesis 1985;6:165-72.
47. Kugelman A, Choy HA, Liu R, Shi MM, Gozal E, Forman HJ. γ-Glutamyl transpeptidase is increased by oxidative stress in rat alveolar L2 epithelial cells. Am J Respir Cell Mol Biol 1994;11:586-92.
48. Levings CS, Siedow JN. Regulation by redox poise in chloroplasts. Science 1995;268:695-6.
49. Ziegler DM. Role of reversible oxidation-reduction of enzyme thiols-disulfides in metabolic regulation. Annu Rev Biochem 1985;54:305-29.
50. Sies H, Brigelius R, Graf P. Hormones, glutathione status and protein S-thiolation. Adv Enzyme Regul 1987;26:175-89.
51. Meyer M, Schreck R, Muller JM, Baeuerle PA. Redox control of gene expression by eukaryotic transcription factors NF-κB, AP-1 and SRF/TCF. In: Pasquier C, Oliver RY, Auclair C, Packer L, editors. Oxidative stress, cell activation and viral infection. Boston: Birkhauser Verlag, 1994:217-35.
52. Peng YM, Peng YS, Lin Y, Moon T, Roe DJ, Ritenbaugh C. Concentrations and plasma-tissue-diet relationships of carotenoids, retinoids, and tocopherols in humans. Nutr Cancer 1995;23:233-46.
53. Nagasawa H, Mitamura T, Sakamoto S, Yamamoto K. Effects of lycopene on spontaneous mammary tumor development in SHN virgin mice. Anticancer Res 1995;15:1173-8.